# Kaempferol Inhibits MMP-1-Mediated Migration and Invasion in Gemcitabine-Resistant Pancreatic Cancer Cells

**Authors:** Saburo Sugita, Yoichi Matsuo, Masaki Ishida, Yuriko Uehara, Yuki Eguchi, Yuki Denda, Keisuke Nonoyama, Hiromichi Murase, Tomokatsu Kato, Kenta Saito, Takafumi Sato, Yushi Yamakawa, Hiroyuki Sagawa, Ryo Ogawa, Hiroki Takahashi, Akira Mitsui, Shuji Takiguchi

PMC · DOI: 10.3390/nu18030380 · Nutrients · 2026-01-23

## TL;DR

Kaempferol, a plant compound, reduces cancer cell spread by lowering MMP-1 levels in pancreatic cancer cells resistant to gemcitabine.

## Contribution

Kaempferol's novel ability to inhibit MMP-1 and suppress cancer cell migration and invasion in gemcitabine-resistant pancreatic cancer is demonstrated.

## Key findings

- Kaempferol reduces MMP-1 protein levels in gemcitabine-resistant pancreatic cancer cells.
- Kaempferol treatment suppresses migration and invasion of resistant cancer cells.
- Kaempferol inhibits Akt and NF-κB signaling pathways in these cells.

## Abstract

Background: Pancreatic cancer (PaCa) has an extremely poor prognosis. This malignancy rapidly acquires resistance to gemcitabine (GEM), a key chemotherapeutic agent, yet the mechanisms underlying this resistance remain incompletely understood. We previously established GEM-resistant (GEM-R) PaCa cell lines and found that these cells exhibit constitutively increased levels of matrix metalloproteinase-1 (MMP-1), which contributes to the invasion and metastasis of PaCa. Kaempferol, a naturally occurring flavonoid found in many plant species, has been shown to exhibit antitumor effects across a range of cancers. Methods/Results: This study demonstrated that non-cytotoxic concentrations of kaempferol significantly decrease MMP-1 protein expression in GEM-R PaCa and suppress their migration and invasion capacities. Western blot analysis demonstrated that MMP-1 protein levels were upregulated in GEM-R PaCa cells and decreased upon kaempferol exposure. In Transwell migration/invasion and wound healing assays, GEM-R PaCa cell lines exhibited enhanced migration and invasion capacities compared with GEM-S cells, whereas kaempferol treatment suppressed these properties, similar to the effects observed by MMP-1 knockdown or treatment with the MMP inhibitor batimastat. Furthermore, kaempferol treatment reduced phosphorylated Akt expression and NF-κB p65 activity. Conclusions: These findings indicate that kaempferol suppresses the migratory and invasive abilities of PaCa cells by downregulating MMP-1 through negative regulation of the Akt and NF-κB signaling cascades, while kaempferol holds promise as a treatment strategy for GEM-R PaCa.

## Linked entities

- **Genes:** MMP1 (matrix metallopeptidase 1) [NCBI Gene 4312], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207]
- **Proteins:** MMP1 (matrix metallopeptidase 1)
- **Chemicals:** kaempferol (PubChem CID 5280863), gemcitabine (PubChem CID 60750), batimastat (PubChem CID 5362422)
- **Diseases:** pancreatic cancer (MONDO:0005192)

## Full-text entities

- **Genes:** RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, MMP1 (matrix metallopeptidase 1) [NCBI Gene 4312] {aka CLG}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}
- **Diseases:** PaCa (MESH:D010190), cancers (MESH:D009369), metastasis (MESH:D009362)
- **Chemicals:** batimastat (MESH:C080985), Kaempferol (MESH:C006552), GEM (MESH:D000093542), flavonoid (MESH:D005419)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12899928/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12899928/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12899928/full.md

---
Source: https://tomesphere.com/paper/PMC12899928